Adimab, a biotechnology company in Lebanon, New Hampshire, was at the forefront of the race to develop COVID-19 antibody treatments. Using cutting-edge antibody discovery technology, researchers at Adimab's laboratories worked to identify and test potential therapeutic antibodies against the coronavirus. These photographs for The New York Times document the scientific research facilities and the urgent work being conducted during the pandemic to find life-saving treatments.
This website uses cookies to improve your experience.